Paragon Wealth Strategies, LLC Monopar Therapeutics Transaction History
Paragon Wealth Strategies, LLC
- $346 Million
- Q4 2023
Shares
3 transactions
Others Institutions Holding MNPR
# of Institutions
13Shares Held
418KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny194KShares$1.32 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA60KShares$406,4430.0% of portfolio
-
Two Sigma Securities, LLC New York, NY47.1KShares$318,5820.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA45.2KShares$305,7800.0% of portfolio
-
Gerber, LLC Columbus, OH28KShares$189,5930.02% of portfolio
About Monopar Therapeutics
- Ticker MNPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,725,800
- Market Cap $86.2M
- Description
- Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe ...